SCHEMBL7777697

SCHEMBL7777697

CN(C)CCn1cc(-c2ccc(Cl)cc2)c(-c2ccc(S(N)(=O)=O)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.46
PTGS1 P23219 4/20 0.46
CA1 P00915 7/20 0.45
CA2 P00918 7/20 0.45
CA9 Q16790 7/20 0.45
CA12 O43570 6/20 0.45
BRAF P15056 1/20 0.42
MAPK3 P27361 1/20 0.42
MAPK1 P28482 1/20 0.42
CA4 P22748 2/20 0.42
CHRNA7 P36544 2/20 0.41
CA3 P07451 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779613 0.90 CA9 (0.45) PTGS2PTGS1CA1CA2CA9
SCHEMBL7780767 0.90 PTGS2 (0.54) PTGS2PTGS1BRAFMAPK3MAPK1
SCHEMBL7780795 0.90 PTGS2 (0.52) PTGS2PTGS1CA1CA2CA9
SCHEMBL7772845 0.89 PTGS2 (0.56) PTGS2PTGS1CA1CA2CA9
SCHEMBL7780139 0.87 MEN1 (0.58) PTGS2CA1CA2CA9CA12
SCHEMBL7779740 0.85 CA1 (0.50) PTGS2PTGS1CA1CA2CA9
SCHEMBL7779955 0.84 PTGS2 (0.51) PTGS2PTGS1CA1CA2CA9
SCHEMBL8627604 0.84 PTGS2 (0.41) PTGS2PTGS1BRAFMAPK3MAPK1
SCHEMBL8758730 0.83 PTGS2 (0.56) PTGS2PTGS1BRAFMAPK3MAPK1
SCHEMBL7772854 0.82 PTGS2 (0.45) PTGS2PTGS1CA1CA2BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed